In a separate study, immunocompetent C57BL/6 mice were treated with or without CD155 and/or CD73 blocking antibodies for 2.5 weeks following engraftment of GL261, mouse glioma, flank tumors (Supplementary Fig. 12A). This evidence concerns the gene NT5E and central nervous system cancer.